Association of medication adherence with treatment preferences: incentivizing truthful self-reporting
Carina Oedingen (),
Raf Gestel,
Samare P. I. Huls,
Georg Granic,
Esther W. Bekker-Grob and
Jorien Veldwijk
Additional contact information
Carina Oedingen: Erasmus University Rotterdam
Raf Gestel: Erasmus University Rotterdam
Samare P. I. Huls: Erasmus University Rotterdam
Georg Granic: Erasmus University Rotterdam
Esther W. Bekker-Grob: Erasmus University Rotterdam
Jorien Veldwijk: Erasmus University Rotterdam
The European Journal of Health Economics, 2025, vol. 26, issue 7, No 8, 1219-1232
Abstract:
Abstract Objective Self-reported medication adherence may be influenced by socially desirable answers and untruthful reporting. Misreporting of adherence behavior can bias estimations of treatment (cost)effectiveness. This study investigated how to induce truthful self-reported medication adherence and evaluated how self-reported (truth-induced vs. regularly reported) medication adherence and treatment preferences were associated. Methods Medication adherence was measured after a discrete choice experiment eliciting stated preferences for Multiple Sclerosis (MS)-treatments. Data was collected among MS-patients in three Western countries. Half of the sample was randomized to ‘choice-matching’, a novel mechanism which induces truthfulness. It financially compensates respondents based on their self-reported adherence and guesses about other respondents’ adherence. To investigate the impact of truth-incentivized adherence reporting on preference heterogeneity, interaction effects between medication adherence and treatment preferences were tested separately within the choice-matching and the ‘standard’ group. Results The sample comprised 380 MS-patients (mean age 41y, 69% female). Respondents in the choice-matching group reported a lower medication adherence compared to the standard group (always adherent: 39.3% vs. 46.6%). Mixed logit models showed significant interaction effects: in the choice-matching group, higher medication adherence resulted in lower utility for pills twice/day compared to injections three times/week (p = 0.019), while in the standard group, respondents with higher medication adherence preferred pills once/day compared to injections three times/week (p = 0.005). Conclusion Choice-matching likely encouraged respondents to report their true medication adherence. Linking truthful behavior to patients’ preferences allows for a better understanding of preference heterogeneity and helping to make decisions that fit patients’ true preferences.
Keywords: Medication adherence; Treatment preferences; Truthful self-reports; Incentivizing; Discrete choice experiment; Choice-matching (search for similar items in EconPapers)
Date: 2025
References: View complete reference list from CitEc
Citations:
Downloads: (external link)
http://link.springer.com/10.1007/s10198-025-01760-z Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:26:y:2025:i:7:d:10.1007_s10198-025-01760-z
Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2
DOI: 10.1007/s10198-025-01760-z
Access Statistics for this article
The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg
More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().